Showing 1 - 10 of 17 Other

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Beatriz Efron

Phone: 713.363.8890

The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Caroline Perry

Phone: 346.238.0307

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >

Status: Enrolling

Investigator: Maen Abdelrahim

Study Coordinator: Denesha Potts

Phone: 713.441.6011

This is an open-label, phase 2 comparative study to assess the safety, tolerability, and preliminary efficacy of nal-IRI in combination with other anticancer therapies in patients with advanced pancreatic adenocarcinoma who have not received pri ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Beatriz Efron

Phone: 713.363.8890

The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >

Status: Open Not Enrolling

Investigator: Richard Klucznik

Study Coordinator: Elmira Ramos

Phone: 713.441.3248

The primary objective of this study is to gather post market data on the Penumbra SMART Coil™ System in the treatment of intracranial aneurysms and other malformations ... Read more >

Status: Enrolling

Investigator: Danielle Antosh

Study Coordinator: Alexandra Villanueva

Phone: 713.441.3879

This randomized, double-blind, placebo-controlled, multi-center, confirmatory study will evaluate the efficacy and safety of Cook MyoSite Incorporated Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) compared to a placebo ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Caroline Perry

Phone: 346.238.0307

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >

Status: Active

Investigator: Rose Khavari

Study Coordinator: Hamida Rajab

Phone: 713.363.9154

The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units [U] and 800 U), compared to placebo in reducing urinary incontinence (UI) in adult subjects treated fo ... Read more >

Status: Enrolling

Investigator: Jean Bismuth

Study Coordinator: Kim Donlon

Phone: 713.441.9394

This study is a prospective, multicenter, non-randomized single-arm study to assess the feasibility of the treatment of DeBakey Type I/II aortic dissections with the GORE® TAG® Thoracic Branch Endoprosthesis system. ... Read more >

Status: Open Not Enrolling

Investigator: Eric Peden

Study Coordinator: Kim Donlon

Phone: 713.441.9394

This trial will evaluate the safety and efficacy of concentrated bone marrow aspirate (cBMA) to prevent or delay major amputation and/or death in subjects with critical limb ischemia (CLI) due to severe peripheral arterial disease (PAD). ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Caroline Perry

Phone: 346.238.0307

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Caroline Perry

Phone: 346.238.0307

The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 3045 patients and its objective is to monitor patients for ap ... Read more >

Status: Enrolling

Investigator: Eamonn Quigley

Study Coordinator: Jomy Macaden

Phone: 346.238.5043

The purpose of this study is to improve the diagnosis of irritable bowel syndrome (IBS). There appear to be different types of IBS and this study aims to clarify which type of IBS patients in this study may have. For example, some patients have ... Read more >

Status: Enrolling

Investigator: Colin Barker

Study Coordinator: Amber Jacobs

Phone: 713.441.3905

The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transca ... Read more >

Status: Enrolling

Investigator: Joshua Swan

Study Coordinator: Elsie Rizk

Phone: 832.946.0487

Ventilated ICU patients frequently have sepsis and the majority have delirium, a form of brain dysfunction that is an independent predictor of increased risk of dying, length of stay, costs, and prolonged cognitive impairment in survivors. Unive ... Read more >

Status: Open Not Enrolling

Investigator: Dale Hamilton

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

UX023T-CL201 is an, open-label, Phase 2 study. The study will be conducted in adults aged 18 years or older with TIO or ENS whose tumor/skin lesion is inoperable to assess the efficacy and safety of KRN23 administered via subcutaneous injections ... Read more >

Status: Open Not Enrolling

Investigator: Dale Hamilton

Study Coordinator: Melissa Whipple

Phone: 713.441.3247

The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH). A Bone Substudy will evaluate the effects of single-blind KRN23 vers ... Read more >